Neutrophil‐to‐lymphocyte ratio at the start of the second course of durvalumab plus tremelimumab therapy predicts therapeutic efficacy in patients with advanced hepatocellular carcinoma: A multicenter analysis

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Takanori Suzuki, Kentaro Matsuura, Satoshi Sobue, Daisuke Kato, Katsumi Hayashi, Hiromu Kondo, Kaiki Anbe, Tsutomu Mizoshita, Kohei Okayama, Fumihiro Okumura, Yoshihide Kimura, Atsushi Ozasa, Hiroki Inada, Takayuki Tokunaga, Satoshi Narahara, Hayato Kawamura, Kei Fujiwara, Shunsuke Nojiri, Hiromi Kataoka, Yasuhito Tanaka
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Hepatology Research
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet